[Translation] A Phase Ib randomized, double-blind, placebo-controlled, multiple intravenous push clinical trial of SAR107375E injection in healthy Chinese adult subjects to investigate its safety, tolerability, pharmacokinetics, and preliminary pharmacodynamics
主要目的:评估中国健康成年受试者多次静脉推注(推注时间约 10min)SAR107375E 注射液的安全耐受性和人体药代动力学(PK)特征;次要目的:评估 SAR107375E 注射液多次静脉推注的药效学评价指标及特征。
[Translation] The primary objective is to evaluate the safety, tolerability and pharmacokinetic (PK) characteristics of SAR107375E injection after multiple intravenous pushes (injection time is approximately 10 minutes) in healthy Chinese adult subjects. The secondary objective is to evaluate the pharmacodynamic evaluation indicators and characteristics of multiple intravenous pushes of SAR107375E injection.